Purchase Order HT942525P0036

Award Date 3/3/25
Potential Completion Date 10/2/25
Potential Value $250K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Worth, TX 76107, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $249,726.25 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Memsel Inc., a small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of an &quot;Advanced Hydrogel-Based Drug Delivery System for Enhanced Neuroprotection in Traumatic Brain Injuries&quot; and has a period of performance through May 6, 2025. The contract was set aside for small businesses.</p>
This federal contract award is for a Small Business Innovation Research (SBIR) Phase I effort by Altrazeal Life Sciences Inc., doing business as Uluru, to develop an &quot;Innovative Adaptive Drug Delivery System Enhanced Neuroprotection Repair Traumatic Brain Injuries from Penetrating Trauma Open Skull Fractures in Low Resource Envir.&quot; The $249,999.96 firm fixed-price contract was awarded by the Defense Health Agency (DHA) on October 7, 2024 and runs through May 6, 2025. The research is...
The U.S. Defense Health Agency (DHA) has awarded a Small Business Innovation Research (SBIR) Phase I contract worth $249,999.06 to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The contract, titled &quot;BRAIN SHIELD: A FIELD-DEPLOYABLE HYDROGEL DRUG DELIVERY SYSTEM FOR LOCALIZED TREATMENT OF TBI MEDICAL R AND D&quot;, is focused on the development of a field-deployable hydrogel drug delivery system for the localized treatment of traumatic brain injuries (TBI). As a small...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Neurotheranostics Inc., a minority-owned small disadvantaged business. The contract, valued at $146,079.20, is for research to develop a point-of-injury therapy to maintain and stabilize moderate-to-severe traumatic brain injury (TBI). The contract is a firm-fixed-price definitive contract, with the work to be performed in Walled Lake, Michigan. This SBIR Phase I contract...
This is a SBIR (Small Business Innovation Research) Phase II contract awarded by the Defense Health Agency to Innosense Corporation, a small disadvantaged minority-owned business. The $999,998.59 contract is for research and development work related to the SBIR program. SBIR Phase II contracts provide funding for further development and prototyping of innovative technologies that were initially explored in a Phase I award. The contract is a cost-plus-fixed-fee type, which is common for this type...
This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a &quot;Hemostatic Agent&quot; under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
This is a Definitive Contract awarded by the Defense Health Agency (DHA) to Chromologic LLC, a small business contractor, under the Small Business Innovation Research (SBIR) Program. The contract, with a Firm Fixed Price of $999,912.00, is for the development of a &quot;Self-Healing Elastomer for Medical Simulation &amp; Training&quot; as part of DHA's Medical R&amp;D efforts. Chromologic, a Minority Owned, American Indian Owned, and Subcontinent Asian American Owned Limited Liability Company,...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Applied Tissue Technologies LLC, a for-profit limited liability company. The contract, valued at $420,308.75, is for the &quot;Development of Technologies that Address the Complex Architecture of the Face during the Treatment of Severe Facial Burn Injury&quot;. This SBIR Phase II contract was awarded under the Major Program Code S10. The contract is a Definitive Contract with a...
This is a $74,934 firm-fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Nanomatronix LLC, a small business, under the SBIR program. The contract modifies an existing advanced micro-physiological brain injury technology platform to include cerebral organoids. Nanomatronix LLC has a history of providing research and development services related to traumatic brain injury, AI, cryptography, fiber optics, and water recovery through past prime federal contracts, many...
This award is for a $1,074,903.98 Firm Fixed Price contract under the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) program. The contract was awarded to Chromologic LLC, a minority-owned small business, for the development of a Phase II project titled &quot;In-Line, Non-Invasive, Non-Destructive Cell Monitoring in Dynamically Growing Cultures&quot;. The project was solicited under DHA SBIR Topic DHA18-006, and the work is to be performed in Monrovia, California....

This is a $249,999.84 Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Acatechol, Inc., a minority-owned small business located in Pasadena, California. The contract is for the development of "bioinspired chitosan-based hydrogels for neuroprotective treatment for traumatic brain injury" under the DHA SBIR topic DHA242-003. The contract has a performance period ending on October 2, 2025. Acatechol, Inc. is a for-profit corporation that specializes in developing innovative anti-infective coatings and surface technologies for medical devices, with a focus on preventing healthcare-associated infections. The company has received multiple federal grant awards to support its research and development initiatives, including from the National Science Foundation and the National Institute of Allergy and Infectious Diseases.

Generated 5/27/25, 9:55 AM